CLINICAL_TRIALS
trial_result
· 2024-05-14
Clinical Trial Update: Gan & Lee Insulin Glargine Target Type (1) Evaluating Research [Phase 3]
Summary
A Phase 3 trial evaluating insulin glargine for Type 1 diabetes completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gan and Lee Pharmaceuticals, USA | Conditions: Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED | Results posted: 2024-05-14